Akoya to provide spatial phenotyping tools to Chan Zuckerberg Initiative
Akoya Biosciences will offer its Codex single-cell, whole-tissue imaging capabilities to the Chan Zuckerberg Initiative's grantees to fuel next-generation biological discoveries. Read More
SciBite, L7 Informatics to offer ontology management for life sciences
Elsevier company SciBite and L7 Informatics are partnering to deliver ontology management to support discovery and collaboration in the life sciences. Read More
Novavax touts COVID-19 vaccine results
Novavax is highlighting study results that demonstrate the efficacy of its COVID-19 vaccine, NVX-CoV2373, as well as a new COVID-19 vaccine it is developing for variants of the disease. Read More
Twist, Regeneron partner on genetics NGS panel
Twist Bioscience is collaborating with Regeneron subsidiary Regeneron Genetics Center to launch a custom next-generation sequencing (NGS) population genetics genotyping assay. Read More
CEBINA launches Danube Labs to develop European biotech
The Central European Biotech Incubator and Accelerator (CEBINA) has launched Danube Labs, a partnership with Evotec SE, to develop biotech from sources in central and Eastern Europe. Read More
AbSci acquires Totient
Synthetic biology firm AbSci has acquired human immune response discovery company Totient. The deal adds antibody and therapeutic target technology to AbSci's range of offerings. Read More
Inceptor Bio to establish cell and gene therapy company portfolio
Inceptor Bio has raised $26 million in seed funding to create a portfolio of companies focused on developing next-generation cell and gene therapies targeting cancer based on the company's advanced manufacturing platform. Read More
Vor, Abound Bio to develop multitargeted CAR T therapies
Vor Biopharma has entered into a multiyear strategic collaboration and license agreement with Abound Bio to research both single- and multitargeted chimeric antigen receptor (CAR) T-cell treatments. Read More
Moderna files U.S. EUA for COVID-19 vaccine in adolescents
Moderna announced it has requested an emergency use authorization (EUA) from the U.S. Food and Drug Administration for its COVID-19 vaccine in adolescents. Read More
Senda accelerates drug development platform with $98M in new funding
Senda Biosciences announced it has closed $98 million in financing to bring the company's platform and its therapeutic programs into clinical trials. Read More
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Connect
